Company Financials

CM Life Sciences III, Inc. Financials

United States dollar

business CM Life Sciences III, Inc. Company Profile

Main Stock Listing

NASDAQ: CMLT

Market Capitalization $687.9 Million as of Dec. 1, 2021

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE
Price to Sales TTM $
Price to Book MRQ $
Enterprise to Revenue
Enterprise to EBITDA

Financial Reports as of Sep. 30, 2021

Financials

Fiscal Year Ends
Most Recent Quarter 2021-09-30
Profit Margin 0.00%
Operating Margin 0.00%
Return on Assets TTM %
Return on Equity TTM %

Income Statement

Revenue TTM $None
Revenue per Share TTM $
Quarterly Revenue Growth %
Gross Profit TTM $None
EBITDA $None
Net Income to Common TTM $None
Diluted EPS TTM $
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $2,085,607
Total Cash per Share MRQ $0.03
Total Debt MRQ $
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 98.14
Book Value per Share MRQ $-1.05

Cash Flow

Operating Cash Flow TTM $None
Levered Free Cash Flow TTM $None

CMLT Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 55,200,000
Float Shares None
Avg 10 Volume 616,939
Avg 30 Volume None
Shares Short 962,529
Short Ratio 8.82
Short % of Shares %
% Held by Insiders 0.00%
% Held by Institutions 70.48%

Stock Price Summary

Beta
Fifty Two Week Low $8.29
Fifty Two Week High $11.10
Fifty Two Week Change -0.14%
Day 50 MA $9.90
Day 200 MA $10.00

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $
Trailing Annual Dividend Yield %
Payout Ratio %
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date